In Vitro Pharmacodynamic Evaluation of Organoids

I. Service Introduction

The in vitro assessment of the efficacy of compounds to be tested against organoid models is a necessary step early in the development of antiviral drugs. Organoid models play an important role in high-throughput drug screening in large compound libraries, detection of single or multi-drug concentrations, rapid discovery of screened drugs, and timely evaluation and optimization of drug effects.

II. Service Cases

·  Evaluation of targeted drugs for drug-resistant lung cancer

· ADC drug evaluation for breast cancer

·  Colorectal Cancer Clinical Drug Evaluation

·  Stomach Cancer Clinical Drug Evaluation

·  Ovarian Cancer Clinical Drug Evaluation

·  Endometrial Cancer Clinical Drug Evaluation

·  Pancreatic Cancer Clinical Drug Evaluation

·  Liver Cancer Clinical Drug Evaluation 

Case Studies

·  Case of Clinical Drug Evaluation Service for Gastric Cancer

· Pancreatic Cancer Clinical Drug Evaluation Service Cases

· Colorectal Cancer Clinical Drug Evaluation Service Cases

· Liver Cancer Clinical Drug Evaluation Service Cases

· Ovarian Cancer Clinical Drug Evaluation Service Cases

OCT002 P2 Acting Drug: Paclitaxel (μM)